Competing endogenous RNA (CeRNA)

In molecular biology, competing endogenous RNAs (abbreviated ceRNAs) regulate other RNA transcripts by competing for shared microRNAs.[1]

Summary

MicroRNAs (miRNA) are an abundant class of small, non-coding RNAs (~22nt long), which negatively regulate gene expression at the levels of messenger RNAs (mRNAs) stability and translation inhibition. The human genome contains over 500 miRNA, each one targeting hundreds of different genes. It is estimated that half of all genes of the genome are targets of miRNA, spanning a large layer of regulation on a post-transcriptional level.[2] The seed region, which comprises nucleotides 2-8 of the 5’ portion of the miRNA, is particularly crucial for mRNA recognition and silencing.[3]

Recent studies have shown that the interaction of the miRNA seed region with mRNA is not unidirectional, but that the pool of mRNAs, transcribed pseudogenes, long noncoding RNAs (lncRNA),[4] circular RNA (circRNA) [5][6] compete for the same pool of miRNA thereby regulating miRNA activity.[7] These competitive endogenous RNAs (ceRNAs) act as molecular sponges for a microRNA through their miRNA binding sites (also referred to as miRNA response elements, MRE), thereby de-repressing all target genes of the respective miRNA family. Experimental evidence for such a ceRNA crosstalk has been initially shown for the tumor suppressor gene PTEN, which is regulated by the 3’ untranslated region (3'UTR) of the pseudogene PTENP1 in a DICER-dependent manner.[8]

A new mechanism has recently been shown in which two closely spaced MREs (of the same or of different miRNA families) can cooperatively sequester miRNAs and thereby significantly boost a ceRNA effect.[9] For a cooperative effect to be considered two adjacent MREs however have to be of miRNA families that are expressed high enough to actively repress targets and to be less than 58 nucleotides apart.

The biological relevance of the ceRNA hypothesis is been actively debated and has been challenged by a group of researchers that performed a quantitative assessment of different miRNA families (highly and lowly expressed) and their binding sites in liver and embryonic stem cells as described below.[9][10]

Debate about the Physiological Relevance of the ceRNA Hypothesis

Two recent studies by Bosson et al (2014) and Denzler et al. (2014) have empirically assessed the ceRNA hypothesis by quantifying the number MREs that must be added to detect ceRNA-mediated gene regulation.[10][11] Both studies agree that determining the number of transcriptomic miRNA-binding sites is crucial for evaluating the potential for ceRNA regulation and that miRNA binding sites are generally higher than the number of miRNA molecules. However, they differ in two aspects: (1) the experimental approaches used to determine the number of ‘‘effective’’ transcriptomic miRNA-binding sites and (2) the impact miRNA concentrations have on the number of binding sites that must be added to detect target gene derepression. The discrepancies between these studies lead to different conclusions with respect to the likelihood of observing ceRNA effects in natural settings, with Bosson et al. observing a ceRNA effect at physiologically plausible and Denzler et al. at unphysiological competitor levels. In an un updated study, Denzler et al. (2016) has revisited the discrepancies between the two studies and has shown that while miRNA levels define the extent of repression, they have little effect on the number of binding sites that need to be added to observe ceRNA-mediated regulation.[9] Using the same cells and experimental systems as the two studies they suggested that the number of binding sites are very high and better reflects the estimates of the study by Denzler et al. (2014), and that low-affinity/background miRNA sites (such as 6-nt sites, offset 6-nt sites, non-canonical sites) significantly contribute to competition.[9] Due to this large number of background sites their model suggests that prospects of observing an effect from a ceRNA are greatly reduced.

Opponents of the ceRNA hypothesis point out that irrefutable proof of ceRNA-mediated gene regulation still remains to be shown, since most studies either overexpress RNA transcripts at unphysiological levels [12][13] or lack seed mutation controls when up- or down-regulating potential ceRNA transcripts.[1][14] The ceRNA field would benefit from future studies in which the effect of a ceRNA regulator is shown by precise seed mutation in the genome of all miRNA binding sites that are suggested to be involved in mediating the effect.

Supporters of the ceRNA hypothesis believe that this experiment is challenging and would not provide any further evidence since many 3' UTR sites can affect the regulation of one target and mutating them may have unintended consequences on mRNA structure or regulation by other factors. It is further criticized that the studies by Denzler et al. only focus on competition for a single miRNA. Since ceRNA regulations are orchestrated through the cooperative effect of multiple miRNA families, [15] the study by Denzler et al. does not represent a typical ceRNA competitor and can therefore not be used to generalize.

Experimentally validated ceRNA Regulators and ceRNA Networks

The PTEN ceRNA Network

PTEN is a critical tumor suppressor gene which is frequently altered in multiple human cancers and is a negative regulator of the oncogenic Phosphoinositide 3-kinase/Akt signaling pathway. Three recent studies have identified and successfully validated protein-coding transcripts as PTEN ceRNAs in prostate cancer,[7] glioblastoma[16] and melanoma.[17] PTEN ceRNAs CNOT6L, VAPA and ZEB2 have been shown to regulate PTEN expression, PI3K signaling, and cell proliferation in a 3’UTR- and microRNA-dependent manner.[7][17] Similarly, in glioblastoma, siRNA-mediated silencing of 13 predicted PTEN ceRNAs including Retinoblastoma protein (RB1), RUNX1 and VEGFA downregulated PTEN expression in a 3’UTR-dependent manner and increased tumor cell growth.[16]

Additionally, PTEN’s non protein-coding pseudogene, PTENP1, is able to affect PTEN expression, downstream PI3K signaling and cell proliferation by directly competing for PTEN-targeting microRNAs.[8]

Pan-Cancer and CLIP-Seq-supported ceRNA regulatory networks[18] has been constructed and is available at http://starbase.sysu.edu.cn/, computational predicted ceRDB has been generated and is available at http://www.oncomir.umn.edu/cefinder/

Linc-MD1

Linc-MD1, a muscle-specific long non-coding RNA, activates muscle-specific gene expression by regulating expression of MAML1 and MEF2C via antagonizing miR-133 and miR-135.[19] Whether Linc-MD1 regulates miRNA activity by sequestering miRNA through a typical ceRNA mechanism or if the highly complementary miR-133 site regulates miRNA activity through target-directed degradation remains to be shown.

BRAFP1

BRAFP1, the BRAF (gene) pseudogene, has been implicated in the development of cancer, including B-cell lymphoma, by acting as a ceRNA for BRAF. Upregulation of BRAFP1 led to an overexpression of the BRAF oncogene.[14]

Hepatitis C virus (HCV)

Hepatitis C has shown been suggested to regulate miR-122 through be a ceRNA mechanism when overexpressed in Huh-7.5 cells.[20] It however still remains to be shown whether Hepatitis C can reach the high titers necessary in vivo in order to modulate gene expression through a ceRNA mechanism.

KRAS1P

Another pseudogene shown to have ceRNA activity is that of the proto-oncogene KRAS, KRAS1P, which increases KRAS transcript abundance and accelerates cell growth.[8]

CD44

The CD44 3’UTR has been shown to regulate expression of the CD44 protein and cell cycle regulation protein, CDC42, by antagonizing the function of three microRNAs - miR-216, miR-330 and miR-608.[12]

Versican

The versican 3’UTR has been shown to regulate expression of the matrix protein fibronectin via antagonizing miR-199a function.[13][21]

HSUR 1, 2

T cells transformed by the primate virus Herpesvirus saimiri (HVS) have been shown to express viral U-rich noncoding RNAs called HSURs. Several of these HSURs are able to bind to and compete for three host-cell microRNAs and thus regulate host-cell gene expression.[22]

ESR1

ESR1 has been shown to be regulated by multiple miRNAs that are highly expressed in ER-negative breast cancer, and its 3' UTR was shown to regulate and be regulated by 3' UTRs of CCND1, HIF1A and NCOA3.[15]

HULC

Highly Up-regulated in liver cancer (HULC) is one of the most upregulated of all genes in hepatocellular carcinoma. CREB (cAMP response element binding protein) has been implicated in the upregulation of HULC.[23] HULC RNA inhibits miR-372 activity through a ceRNA function, leading to derepression of one of its target genes, PRKACB, which can then induce the phosphorylation and activation of CREB. Overall, HULC lncRNA is part of a self-amplifying autoregulatory loop in which it sponges miR-372 to activate CREB, and in turn upregulates its own expression levels.

ceRNA in bacteria

Bacteria do not have miRNA, and instead ceRNAs in these organisms compete for small RNAs (sRNAs) or RNA-binding proteins (RBPs).[24] Similarly, competition by ceRNAs for RNA-binding proteins has also been reported in eukaryotic cells.[25]

See also

External links

References

  1. 1 2 Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP (August 2011). "A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?". Cell. 146 (3): 353–8. doi:10.1016/j.cell.2011.07.014. PMC 3235919Freely accessible. PMID 21802130.
  2. ↑ Friedman, R. C. Farh, K. K. H. Burge, C. B. Bartel, D. P. (2009). "Most mammalian mRNAs are conserved targets of microRNAs". Genome Research. 19 (1): 92–105. doi:10.1101/Gr.082701.108.
  3. ↑ Lewis, B. P. Burge, C. B. Bartel, D. P. (2005). "Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets". Cell. 120 (1): 15–20. doi:10.1016/j.cell.2004.12.035. PMID 15652477.
  4. ↑ Cesana, M. Cacchiarelli, D. Legnini, I. Santini, T. Sthandier, O. Chinappi, M. Tramontano, A. Bozzoni, I. (2011). "A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA". Cell. 147 (2): 358–69. doi:10.1016/j.cell.2011.09.028. PMC 3234495Freely accessible. PMID 22000014.
  5. ↑ Hansen, T. B. Jensen, T. I. Clausen, B. H. Bramsen, J. B. Finsen, B. Damgaard, C. K. Kjems, J. (2013). "Natural RNA circles function as efficient microRNA sponges". Nature. 495 (7441): 384–388. Bibcode:2013Natur.495..384H. doi:10.1038/nature11993. PMID 23446346.
  6. ↑ Memczak, S. Jens, M. Elefsinioti, A. Torti, F. Krueger, J. Rybak, A. Maier, L. Mackowiak, S. D. Gregersen, L. H. Munschauer, M. Loewer, A. Ziebold, U. Landthaler, M. Kocks, C. le Noble, F. Rajewsky, N. (2013). "Circular RNAs are a large class of animal RNAs with regulatory potency". Nature. 495 (7441): 333–338. Bibcode:2013Natur.495..333M. doi:10.1038/nature11928. PMID 23446348.
  7. 1 2 3 Tay Y.; Kats L.; Salmena L.; Weiss D.; Tan S.M.; Ala U.; Karreth F.; Poliseno L.; Provero P.; et al. (2011). "Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs". Cell. 147 (2): 344–357. doi:10.1016/j.cell.2011.09.029. PMC 3235920Freely accessible. PMID 22000013.
  8. 1 2 3 Poliseno, L. Salmena, L. Zhang, J. Carver, B. Haveman, W. J. Pandolfi, P. P. (2012). "A coding-independent function of gene and pseudogene mRNAs regulates tumour biology". Nature. 465 (7301): 1033–1038. Bibcode:2010Natur.465.1033P. doi:10.1038/nature09144. PMC 3206313Freely accessible. PMID 20577206.
  9. 1 2 3 4 Denzler, R. McGeary, S. E. Title, A. Agarwal, V. Bartel, D. P. Stoffel, M. (2016). "Impact of MicroRNA Levels, Target-Site Complementarity, and Cooperativity on Competing Endogenous RNA-Regulated Gene Expression". Molecular Cell. 64: 1–15. doi:10.1016/j.molcel.2016.09.027.
  10. 1 2 Denzler, R. Agarwal, V. Stefano, J. Bartel, D. P. Stoffel, M. (2014). "Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance". Molecular Cell. 54 (5): 766–776. doi:10.1016/j.molcel.2014.03.045.
  11. ↑ Bosson, Andrew D.; Zamudio, Jesse R.; Sharp, Phillip A. (2014-11-06). "Endogenous miRNA and target concentrations determine susceptibility to potential ceRNA competition". Molecular Cell. 56 (3): 347–359. doi:10.1016/j.molcel.2014.09.018. ISSN 1097-4164. PMC 5048918Freely accessible. PMID 25449132.
  12. 1 2 Jeyapalan Z.; Deng Z.; Shatseva T.; Fang L.; He C.; Yang B.B. (2011). "Expression of CD44 3'-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis". Nucleic Acids Research. 39 (8): 3026–3041. doi:10.1093/nar/gkq1003. PMC 3082902Freely accessible. PMID 21149267.
  13. 1 2 Lee D.Y., Jeyapalan Z., Fang L., Yang J., Zhang Y., Yee A.Y., Li M., Du W.W., Shatseva T.; et al. (2010). Najbauer, Joseph, ed. "Expression of versican 3'-untranslated region modulates endogenous microRNA functions". PLoS ONE. 5 (10): e13599. Bibcode:2010PLoSO...513599L. doi:10.1371/journal.pone.0013599.
  14. 1 2 Karreth, Florian A.; Reschke, Markus; Ruocco, Anna; Ng, Christopher; Chapuy, Bjoern; Léopold, Valentine; Sjoberg, Marcela; Keane, Thomas M.; Verma, Akanksha (2015-09-04). "The BRAF Pseudogene Functions as a Competitive Endogenous RNA and Induces Lymphoma In Vivo". Cell. 161 (2): 319–332. doi:10.1016/j.cell.2015.02.043. ISSN 0092-8674. PMID 25843629.
  15. 1 2 Chiu, Hua-Sheng; Llobet-Navas, David; Yang, Xuerui; Chung, Wei-Jen; Ambesi-Impiombato, Alberto; Iyer, Archana; Kim, Hyunjae "Ryan"; Seviour, Elena G.; Luo, Zijun; Sehgal, Vasudha; Moss, Tyler; Lu, Yiling; Ram, Prahlad; Silva, José; Mills, Gordon B.; Califano, Andrea; Sumazin, Pavel (February 2015). "Cupid: simultaneous reconstruction of microRNA-target and ceRNA networks". Genome Research. 25 (2): 257–67. doi:10.1101/gr.178194.114. PMID 25378249.
  16. 1 2 Sumazin P.; Yang X.; Chiu H.-S.; Chung W.-J.; Iyer A.; Llobet-Navas D.; Rajbhandari P.; Bansal M.; Guarnieri P.; et al. (2011). "An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma". Cell. 147 (2): 370–381. doi:10.1016/j.cell.2011.09.041. PMC 3214599Freely accessible. PMID 22000015.
  17. 1 2 Karreth F.A.; Tay Y.; Perna D.; Ala U.; Tan S.M.; Rust A.G.; DeNicola G.; Webster K.A.; Weiss D.; et al. (2011). "In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma". Cell. 147 (2): 382–395. doi:10.1016/j.cell.2011.09.032. PMC 3236086Freely accessible. PMID 22000016.
  18. ↑ Li, JH; Liu, S; Zhou, H; Qu, LH; Yang, JH (Dec 1, 2013). "starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data.". Nucleic Acids Research. 42 (1): D92–7. doi:10.1093/nar/gkt1248. PMID 24297251.
  19. ↑ Cesana M.; Cacchiarelli D.; Legnini I.; Santini T.; Sthandier O.; Chinappi M.; Tramontano A.; Bozzoni I. (2011). "A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA". Cell. 147 (2): 358–369. doi:10.1016/j.cell.2011.09.028. PMC 3234495Freely accessible. PMID 22000014.
  20. ↑ Luna, J.M. Scheel, Troels K.H. Danino, T. Shaw, K.S. Mele, A. Fak, J.J. Nishiuchi, E. Takacs, C.N. Catanese, M.T. de Jong, Y.P. Jacobson, I.M. Rice, C.M. Darnell, R.B. (2015). "Hepatitis C Virus RNA Functionally Sequesters miR-122". Cell. 160 (6): 1099–1110. doi:10.1016/j.cell.2015.02.025.
  21. ↑ Lee DY, Shatseva T, Jeyapalan Z, Du WW, Deng Z, Yang BB (2009). "A 3'-untranslated region (3'UTR) induces organ adhesion by regulating miR-199a* functions.". PLoS ONE. 4 (2): e4527. doi:10.1371/journal.pone.0004527.
  22. ↑ Cazalla D.; Yario T.; Steitz J.A. (2010). "Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA". Science. 328 (5985): 1563–1566. Bibcode:2010Sci...328.1563C. doi:10.1126/science.1187197. PMC 3075239Freely accessible. PMID 20558719.
  23. ↑ Wang J.; Liu X.; Wu H.; Ni P.; Gu Z.; Qiao Y.; Chen N.; Sun F.; Fan Q.; et al. (2010). "CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer". Nucleic Acids Res. 38 (16): 5366–5383. doi:10.1093/nar/gkq285. PMC 2938198Freely accessible. PMID 20423907.
  24. ↑ Bossi, Lionello; Figueroa-Bossi, Nara. "Competing endogenous RNAs: a target-centric view of small RNA regulation in bacteria". Nature Reviews Microbiology. doi:10.1038/nrmicro.2016.129.
  25. ↑ Karreth, Florian A.; Tay, Yvonne; Pandolfi, Pier Paolo (2014-04-28). "Target competition: transcription factors enter the limelight". Genome Biology. 15 (4): 114. doi:10.1186/gb4174. ISSN 1474-760X. PMC 4052382Freely accessible. PMID 25001290.
This article is issued from Wikipedia - version of the 11/15/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.